KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opera (OPRA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Opera (OPRA) over the last 10 years, with Q3 2025 value amounting to $119.0 million.

  • Opera's Cash & Equivalents rose 1407.3% to $119.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.0 million, marking a year-over-year increase of 1407.3%. This contributed to the annual value of $106.0 million for FY2024, which is 2694.45% up from last year.
  • Latest data reveals that Opera reported Cash & Equivalents of $119.0 million as of Q3 2025, which was up 1407.3% from $126.8 million recorded in Q2 2025.
  • In the past 5 years, Opera's Cash & Equivalents registered a high of $166.1 million during Q3 2022, and its lowest value of $52.4 million during Q4 2022.
  • Over the past 5 years, Opera's median Cash & Equivalents value was $103.5 million (recorded in 2025), while the average stood at $109.3 million.
  • Per our database at Business Quant, Opera's Cash & Equivalents surged by 8459.72% in 2022 and then crashed by 4971.73% in 2023.
  • Over the past 5 years, Opera's Cash & Equivalents (Quarter) stood at $102.9 million in 2021, then crashed by 49.05% to $52.4 million in 2022, then surged by 79.08% to $93.9 million in 2023, then soared by 35.09% to $126.8 million in 2024, then dropped by 6.12% to $119.0 million in 2025.
  • Its Cash & Equivalents was $119.0 million in Q3 2025, compared to $126.8 million in Q2 2025 and $103.5 million in Q1 2025.